Article Type
Changed
Fri, 01/04/2019 - 11:17
Display Headline
David Henry's JCSO podcast, January-February 2018

In this podcast, Dr Henry discusses research articles on analgesic management in radiation oncology for painful bone metastases, hospitalizations for fracture in patients with metastatic disease, measurement of physical activity and sedentary behavior in breast cancer survivors, and patient navigators’ personal experiences with cancer and their impact on treatment. He also highlights a New Therapies review article on hallmark tumor metabolism becoming a validated therapeutic target, as well as The JCSO Interview, in which Kenneth Anderson, MD, talks about new myeloma drugs and their associated improved response rates and extended survival. Comments on the approvals of abemaciclib for breast cancer and avelumab and durvalumab for metastatic bladder cancer, and Case Reports on concurrent ipilimumab and CMV colitis refractory to oral steroids, recurrent head and neck cancer presenting as a large retroperitoneal mass, massive liver metastasis from colon adenocarcinoma causing cardiac tamponade, and cardiac pleomorphic sarcoma after placement of Dacron graft round out the line-up of articles. 

Listen to the podcast below.

Audio file

 

Publications
Sections

In this podcast, Dr Henry discusses research articles on analgesic management in radiation oncology for painful bone metastases, hospitalizations for fracture in patients with metastatic disease, measurement of physical activity and sedentary behavior in breast cancer survivors, and patient navigators’ personal experiences with cancer and their impact on treatment. He also highlights a New Therapies review article on hallmark tumor metabolism becoming a validated therapeutic target, as well as The JCSO Interview, in which Kenneth Anderson, MD, talks about new myeloma drugs and their associated improved response rates and extended survival. Comments on the approvals of abemaciclib for breast cancer and avelumab and durvalumab for metastatic bladder cancer, and Case Reports on concurrent ipilimumab and CMV colitis refractory to oral steroids, recurrent head and neck cancer presenting as a large retroperitoneal mass, massive liver metastasis from colon adenocarcinoma causing cardiac tamponade, and cardiac pleomorphic sarcoma after placement of Dacron graft round out the line-up of articles. 

Listen to the podcast below.

Audio file

 

In this podcast, Dr Henry discusses research articles on analgesic management in radiation oncology for painful bone metastases, hospitalizations for fracture in patients with metastatic disease, measurement of physical activity and sedentary behavior in breast cancer survivors, and patient navigators’ personal experiences with cancer and their impact on treatment. He also highlights a New Therapies review article on hallmark tumor metabolism becoming a validated therapeutic target, as well as The JCSO Interview, in which Kenneth Anderson, MD, talks about new myeloma drugs and their associated improved response rates and extended survival. Comments on the approvals of abemaciclib for breast cancer and avelumab and durvalumab for metastatic bladder cancer, and Case Reports on concurrent ipilimumab and CMV colitis refractory to oral steroids, recurrent head and neck cancer presenting as a large retroperitoneal mass, massive liver metastasis from colon adenocarcinoma causing cardiac tamponade, and cardiac pleomorphic sarcoma after placement of Dacron graft round out the line-up of articles. 

Listen to the podcast below.

Audio file

 

Publications
Publications
Article Type
Display Headline
David Henry's JCSO podcast, January-February 2018
Display Headline
David Henry's JCSO podcast, January-February 2018
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 03/26/2018 - 13:15
Un-Gate On Date
Mon, 03/26/2018 - 13:15
Use ProPublica